Glenmark and its partner Canada-based SaNOtize Research & Development Corp. on Wednesday announced the launch of its Nitric Oxide Nasal Spray (NONS) under the brand name FabiSpray in India for…
Ichnos Sciences, Glenmark’s drug discovery subsidiary based in the US, on Tuesday said it has entered into an exclusive agreement with Spanish drugmaker Almirall to out-license its novel monoclonal antibody…
A steep rise in raw material prices has begun to pinch the country’s drug manufacturers to the extent that some have sought government intervention to tame the prices and a…
Glenmark Pharmaceuticals on Thursday said it has received marketing approval for its fixed-dose combination nasal spray, Ryaltris, in 13 countries across the EU and the UK. The company is set…
Mumbai (Maharashtra): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. The PMS study…
